Patents by Inventor Kathryn Eisenmann

Kathryn Eisenmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of formin agonists in overcoming brain tumor radio- and chemo-resistance by targeting tumor microtubes
    Patent number: 11547682
    Abstract: Compositions and methods for inhibiting brain tumor proliferation, or for inhibiting or halting TM formation, invasion, and/or proliferation, or for rendering brain tumor cells sensitive to chemotherapy or radiation, or for treating a brain tumor, or for inducing cell death, involving mDia agonists such as IMM01 and IMM02, are described.
    Type: Grant
    Filed: March 10, 2020
    Date of Patent: January 10, 2023
    Assignee: The University of Toledo
    Inventors: Kathryn Eisenmann, Krista M. Pettee, Kathryn Becker
  • Use of Formin Agonists in Overcoming Brain Tumor Radio- and Chemo-resistance by Targeting Tumor Microtubes
    Publication number: 20200289440
    Abstract: Compositions and methods for inhibiting brain tumor proliferation, or for inhibiting or halting TM formation, invasion, and/or proliferation, or for rendering brain tumor cells sensitive to chemotherapy or radiation, or for treating a brain tumor, or for inducing cell death, involving mDia agonists such as IMM01 and IMM02, are described.
    Type: Application
    Filed: March 10, 2020
    Publication date: September 17, 2020
    Applicant: The University of Toledo
    Inventors: Kathryn Eisenmann, Krista M. Pettee, Kathryn Becker
  • Enhancement of human epidermal melanogenesis
    Publication number: 20050202001
    Abstract: The invention provides methods and compositions that promote sunless tanning in human skin using a MAPK path-way inhibitor, particularly, a MEK-inhibitor, which induces melanogenesis in epidermal melanocytes alone or in combination with a cAMP-elevating agent. The compositions are preferably administered topically to the skin.
    Type: Application
    Filed: April 24, 2003
    Publication date: September 15, 2005
    Inventors: Han-Mo Koo, George Woude, Matt Vanbrocklin, Kathryn Eisenmann